JP2014529579A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014529579A5 JP2014529579A5 JP2014522041A JP2014522041A JP2014529579A5 JP 2014529579 A5 JP2014529579 A5 JP 2014529579A5 JP 2014522041 A JP2014522041 A JP 2014522041A JP 2014522041 A JP2014522041 A JP 2014522041A JP 2014529579 A5 JP2014529579 A5 JP 2014529579A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- enteric formulation
- drug according
- enteric
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11175252.3A EP2550963B1 (de) | 2011-07-25 | 2011-07-25 | Pentamidin-Amidoximsäureesters als Prodrugs und ihre Verwendung als Arzneimittel |
| EP11175252.3 | 2011-07-25 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016173855A Division JP2017039727A (ja) | 2011-07-25 | 2016-09-06 | プロドラッグとしてのペンタミジンアミドキシム酸エステルおよびそれらの薬物としての使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014529579A JP2014529579A (ja) | 2014-11-13 |
| JP2014529579A5 true JP2014529579A5 (https=) | 2015-09-10 |
Family
ID=46514404
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014522041A Withdrawn JP2014529579A (ja) | 2011-07-25 | 2012-07-19 | プロドラッグとしてのペンタミジンアミドキシム酸エステルおよびそれらの薬物としての使用 |
| JP2016173855A Withdrawn JP2017039727A (ja) | 2011-07-25 | 2016-09-06 | プロドラッグとしてのペンタミジンアミドキシム酸エステルおよびそれらの薬物としての使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016173855A Withdrawn JP2017039727A (ja) | 2011-07-25 | 2016-09-06 | プロドラッグとしてのペンタミジンアミドキシム酸エステルおよびそれらの薬物としての使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20130085180A1 (https=) |
| EP (1) | EP2550963B1 (https=) |
| JP (2) | JP2014529579A (https=) |
| KR (1) | KR20140097108A (https=) |
| CN (1) | CN103874491A (https=) |
| AU (1) | AU2012288968B2 (https=) |
| BR (1) | BR112014001787A2 (https=) |
| CA (1) | CA2842355A1 (https=) |
| DK (1) | DK2550963T3 (https=) |
| ES (1) | ES2610652T3 (https=) |
| HR (1) | HRP20170013T1 (https=) |
| HU (1) | HUE030245T2 (https=) |
| LT (1) | LT2550963T (https=) |
| PL (1) | PL2550963T3 (https=) |
| PT (1) | PT2550963T (https=) |
| RS (1) | RS55557B1 (https=) |
| RU (1) | RU2608388C2 (https=) |
| SI (1) | SI2550963T1 (https=) |
| WO (1) | WO2013014059A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112015014836A2 (pt) | 2012-12-21 | 2017-07-11 | Verlyx Pharma Inc | método para tratamento alvo de uma ou mais condições do fígado, e, uso oral de uma quantidade terapeuticamente eficaz de pelo menos um análogo de diamidina ou um sal farmaceuticamente aceitável da mesma |
| EP3687514A4 (en) | 2017-09-27 | 2021-06-30 | Ohio State Innovation Foundation | METHODS AND COMPOSITIONS FOR INHIBITING STAT3 |
| US12594265B2 (en) | 2017-09-27 | 2026-04-07 | Ohio State Innovation Foundation | Methods and compositions for inhibition of STAT3 |
| US10835581B2 (en) | 2017-11-28 | 2020-11-17 | University of Pittsburgh—of the Commonwealth System of Higher Education | Method of treating insulin resistance |
| US12398105B2 (en) * | 2018-12-20 | 2025-08-26 | Auransa Inc. | Analogues of pentamidine and uses therefor |
| EP4688745A2 (en) * | 2023-04-07 | 2026-02-11 | Auransa Inc. | Pentamidine analogue polymorphs, formulations, and methods thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4321444A1 (de) * | 1993-06-28 | 1995-01-05 | Bernd Prof Dr Clement | Pharmazeutische Zubereitung |
| US5723495A (en) * | 1995-11-16 | 1998-03-03 | The University Of North Carolina At Chapel Hill | Benzamidoxime prodrugs as antipneumocystic agents |
| US6569853B1 (en) * | 2000-11-06 | 2003-05-27 | Combinatorx, Incorporated | Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders |
| DE102008007381A1 (de) * | 2008-02-01 | 2009-08-13 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co.Kg | Amidine und Guanidine und deren Derivate zur Behandlung von Krankheiten |
-
2011
- 2011-07-25 EP EP11175252.3A patent/EP2550963B1/de not_active Not-in-force
- 2011-07-25 PL PL11175252T patent/PL2550963T3/pl unknown
- 2011-07-25 PT PT111752523T patent/PT2550963T/pt unknown
- 2011-07-25 HU HUE11175252A patent/HUE030245T2/en unknown
- 2011-07-25 SI SI201131053A patent/SI2550963T1/sl unknown
- 2011-07-25 DK DK11175252.3T patent/DK2550963T3/en active
- 2011-07-25 ES ES11175252.3T patent/ES2610652T3/es active Active
- 2011-07-25 LT LTEP11175252.3T patent/LT2550963T/lt unknown
- 2011-07-25 RS RS20170002A patent/RS55557B1/sr unknown
-
2012
- 2012-07-19 CA CA2842355A patent/CA2842355A1/en not_active Abandoned
- 2012-07-19 AU AU2012288968A patent/AU2012288968B2/en not_active Ceased
- 2012-07-19 WO PCT/EP2012/064171 patent/WO2013014059A1/de not_active Ceased
- 2012-07-19 RU RU2014106867A patent/RU2608388C2/ru not_active IP Right Cessation
- 2012-07-19 KR KR1020147004770A patent/KR20140097108A/ko not_active Withdrawn
- 2012-07-19 BR BR112014001787A patent/BR112014001787A2/pt not_active IP Right Cessation
- 2012-07-19 CN CN201280037041.7A patent/CN103874491A/zh active Pending
- 2012-07-19 JP JP2014522041A patent/JP2014529579A/ja not_active Withdrawn
- 2012-10-05 US US13/554,536 patent/US20130085180A1/en not_active Abandoned
-
2016
- 2016-09-06 JP JP2016173855A patent/JP2017039727A/ja not_active Withdrawn
-
2017
- 2017-01-05 HR HRP20170013TT patent/HRP20170013T1/hr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20250028I1 (fi) | Eplonterseeni, valinnaisesti farmaseuttisesti hyväksyttävän suolan muodossa | |
| FR21C1059I2 (fr) | Compositions pharmaceutiques | |
| JP2015512729A5 (https=) | ||
| JP2012143233A5 (https=) | ||
| JP2015503422A5 (https=) | ||
| JP2012126725A5 (https=) | ||
| JP2014237817A5 (https=) | ||
| BR302013000149S1 (pt) | Configuração aplicada a um tablet com controlador de jogo integrado. | |
| JP2012030068A5 (https=) | ||
| JP2014517802A5 (https=) | ||
| JP2015501646A5 (https=) | ||
| JP2013181136A5 (ja) | ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置 | |
| JP2015518492A5 (https=) | ||
| JP2016540026A5 (https=) | ||
| JP2015512855A5 (https=) | ||
| JP2016540019A5 (https=) | ||
| JP2014529579A5 (https=) | ||
| JP2012209621A5 (https=) | ||
| EP2988734C0 (en) | FORMULATION OF A HARD CAPSULE | |
| JP2014104515A5 (https=) | ||
| JP2015009865A5 (https=) | ||
| JP2015024876A5 (https=) | ||
| ES1078895Y (es) | Mantel enrollable. | |
| CO7020922A2 (es) | Comprimido antiácido | |
| JP2014073263A5 (https=) |